Seminars in Oncology
Volume 36, Issue 4 , Pages 324-337 , August 2009

Sarcomas With Spindle Cell Morphology

  • Paola Collini

      Affiliations

    • Department of Anatomic Pathology, IRCCS Foundation, Istituto Nazionale Tumori, Milan, Italy
    • These authors contributed equally to this work.
    • ,
  • Poul H.B. Sorensen

      Affiliations

    • Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, BC, Canada
    • These authors contributed equally to this work.
    • ,
  • Shreyaskumar Patel

      Affiliations

    • Sarcoma Center, Department of Sarcoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
    • These authors contributed equally to this work.
    • ,
  • Jean-Yves Blay

      Affiliations

    • Centre Leon Berard, Hôpital Edouard Herriot, pav. E and INSERM U590, Lyon, France
    • These authors contributed equally to this work.
    • ,
  • Rolf D. Issels

      Affiliations

    • University Hospital Medical Center Grosshadern, Medical Clinic III, Munich, Germany; and HelmholtzZentrum München, German Research Center for Environmental Health, CCG Hyperthermia, Neuherberg, Germany
    • These authors contributed equally to this work.
    • ,
  • Robert G. Maki

      Affiliations

    • Sarcoma Program, Memorial Sloan-Kettering Cancer Center, New York, NY
    • These authors contributed equally to this work.
    • ,
  • Mikael Eriksson

      Affiliations

    • Department of Oncology, University Hospital, Lund, Sweden
    • These authors contributed equally to this work.
    • ,
  • Xavier Garcia del Muro

      Affiliations

    • Instituto Catalán de Oncología, Barcelona, Spain
    • These authors contributed equally to this work.
    • Corresponding Author InformationAddress correspondence to Xavier Garcia del Muro, MD, Instituto Catalán de Oncología, c/Viladomat 319 Atico 1, Barcelona 08029, Spain

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Jean-Yves Blay is supported by CONTICANET Network of Excellence of the 6th FP of the European Commission; Poul H.B. Sorensen has received grants from the Canadian Institutes for Health Research; and Robert G. Maki is supported by Program Project Grant No. P01-CA47179; Cycle for Survival.

Disclosures Jean-Yves Blay: Research support, consulting fees (Pfizer, Novartis, Roche, Glaxo Smith Kline)Robert G. Maki: Research support (Pfizer); honoraria (Ziopharm); testimony (Roche)

PII: S0093-7754(09)00107-9

doi: 10.1053/j.seminoncol.2009.06.007

Seminars in Oncology
Volume 36, Issue 4 , Pages 324-337 , August 2009

Article Tools

* Image Usage & Resolution